Scout · Dec 2025
Scout announced a CARB-X award of up to $6M to advance STI Scout into verification and validation and assess deployment in low- and middle-income settings.
The smart testing platform that unlocks digital health at home.
Public company, workplace, funding, and market signals
Scout (formerly Uh-Oh Labs) is a Santa Clara-based, 2018-founded biotechnology/diagnostics company building the Scout Hub + Scout Connect platform for rapid molecular testing at home and at the point of care. Public sources describe a small team (about 9 people), active product development in COVID-19 and STI diagnostics, and grant-heavy financing from CARB-X plus broader non-dilutive support from NIH-related programs and other institutions.
Primary product
Scout Hub + Scout Connect molecular testing platform (single-use test kits / rapid point-of-care and at-home diagnostics)
Founded
2018
Headquarters
Santa Clara, California, United States
Team size
1-10
Industry
Biotechnology Research
Sub-industry
Point-of-care molecular diagnostics
Offices
0 jobs at Scout
Check back later for new openings
Business model
Stage
seed / grant-backed
Total raised
$7.5M
Latest round
CARB-X award · Dec 2025
Latest amount
$6M
Leadership
Chief Executive Officer
Chief Technology Officer
Head of Marketing & Commercial Strategy
Vice President Operations
Director of Software Engineering
Chief Financial Officer
Investors
Mission-driven, science-heavy, early-stage team focused on lowering diagnostic cost and increasing access; public profiles emphasize fast execution, cross-functional engineering, and commercial validation.
Compensation
No reliable public compensation signal found; third-party salary pages were inconsistent and not treated as authoritative.
Pricing
Primarily B2B clinic/device-and-consumables with potential reimbursement via applicable CPT codes; pricing not publicly posted.
Differentiators
Technology
Customers
Competitors
Estimated revenue
$5M-$8.6M
Estimated monthly visits
2.6K
Traffic estimate as of Jun 2026
Scout · Dec 2025
Scout announced a CARB-X award of up to $6M to advance STI Scout into verification and validation and assess deployment in low- and middle-income settings.
CARB-X · Dec 2025
CARB-X’s news post on Scout’s additional award; cites next-generation CT/NG system, LMIC pilot plans, and the prior $1M award.
GenomeWeb · Dec 2025
Trade coverage of the follow-on CARB-X funding round and the company’s next-generation hub, cost targets, and LMIC strategy.
PRNewswire / Scout · Apr 2024
CARB-X awarded up to $1M for STI Scout, describing the platform, sample types, turnaround time, and the company’s broader diagnostic roadmap.
GenomeWeb · Apr 2024
Trade coverage of Scout’s first CARB-X STI award, including product details, FDA EUA context, and market positioning.